One more DNDN DD
Say DNDN DD five times fast. That's right up there with 'toy boat'. lol
Quoting from the pr:
"The survival benefit seen with Provenge is the largest ever reported in this patient population with any therapy," said Dr. Small. "This survival benefit, combined with a favorable safety profile, has the potential to provide an important new treatment option for prostate cancer patients."
They have presented peliminary data to some very impressive panels. Last month they presented peliminary data to J.P. Morgan's Healthcare Symposium. On Saturday, the FINAL DATA will be presented to the University of California's Symposium on Prostate Cancer.
Finally, Provenge has a 'Fast Track Designation' and this trial has been under a 'Special Protocol Assessment Agreement' with the US Food and Drug Administration.
Later all,
Bo
